期刊文献+

溃疡性结肠炎结肠黏膜不同时期内选择素表达及意义 被引量:1

原文传递
导出
摘要 目的探讨溃疡性结肠炎不同时期选择素表达及其意义。方法采用前瞻性研究设计,选择2007年7—12月UC患者,采用组织匀浆及ELISA检测结肠黏膜不同时期内选择素的表达。结果①共29例资料完整患者进入资料统计整理;②活动期UC患者病变黏膜及正常黏膜P选择素表达均明显高于正常对照组(F=35.2,P〈0.01);E选择素在UC患者正常及病变黏膜同样高表达,但两种选择素异常表达在病变黏膜及正常黏膜中无统计学差异(t=1.46和1.32,P〉0.10;③UC缓解期内P、E选择素高表达与uc复发频次关系密切(X^2=4.201和5.040,P〈0.05)。结论选择素P、E可能是uc发病重要炎性介质,在UC发病中可能无决定性作用。但选择素高表达可能与UC复发频次关系密切。 Objective To investigate the expression of selectin in different stage and position of colon mucos in UC. Methods The study was prospectively designed. The cases of UC from 2007.7 to 2007.12 was selected and selectin P,E in colon mucos homogenate were detected by ELISA. Results (1)29 cases of UC with whole dates were brought into the last statistic. (2)Slectin P in suffered and normal mucos of UC in active stage was high expressed, compared to healthy group, statistics was significant ( F = 35.2, P 〈 0.01 ). Selectin E was high expressed in mueos of UC with active stage. But there were no statistical difference between normal and suffered mucos( t = 1.46 and 1.32,P 〉 0. 10). (3)In remittance stage, high level of selectin P, E in colon mueos and relapse frequency showed positive correlation(x^2 = 4. 201 and 5. 040,P 〈 0. 05 ). Conclusion Selectin P, E are important inflammation factor in UC and maybe not take a decisive role in the onset of UC. But high level of selectin P,E in remittance stage in colon mucos may have more possibility of relapse.
出处 《中国临床实用医学》 2010年第6期108-109,共2页 China Clinical Practical Medicine
关键词 溃汤性结肠炎 P选择素 E选择素 Uleerative colitis E-selectin Sectin-P
  • 相关文献

参考文献10

  • 1Nielsen OH, Brynskov J, Vainer B. Increased mucosal concentrations of soluble intercellular adhesion molecule-1 ( sICAM-1 ) , sEselectin, and interleukin-8 in active ulcerative colitis. Dig Dis Sci, 1996,41 (9) : 1780-1785.
  • 2欧阳钦,胡品津,钱家鸣,郑家驹,胡仁伟.对我国炎症性肠病诊断治疗规范的共识意见[J].胃肠病学,2007,12(8):488-495. 被引量:751
  • 3Ludwiczek O, Yannier E, Borggraefe I, et al. Imbalance between interleukin-1 agonists and antagonists:relationship to severity of inflammatory bowel disease. Clin Exp Immunol, 2004, 138 ( 2 ) : 323 -329.
  • 4Damen GM, van Lierop P, de Ruiter L, et al. Production of IL12p70 and IL23 by monocyte-derived dendritic cells in children with inflammatory bowel disease. Gut ,2008,57 ( 10 ) : 1480.
  • 5Owezarek D, Cibor D, Szezepanek M, et al. Biological therapy of inflammatory bowel disease. Pol Arch Med Wewn ,2009,119 ( 1-2 ) : 84-88.
  • 6Abreu MT, Plevy S, Sands BE, et al. Selective leukocyte apheresis for the treatment of inflammatory bowel disease. J Clin Gastrocnterol,2007,41 (10) :874-888.
  • 7Varki A. Selectins and other mammalian sialic acid-binding lectins. Curt Opin Cell Biol, 1992,4 (2) :257-266.
  • 8Fagerstam JP, Whiss PA, Storm, M, et al. Expression platelet P-selee tion and detection of soluble P-selection. NYP and RANTES in patients with inflammatory bowel disease. Inflamm Rus,2000,49: 466-476.
  • 9Magro F, Araujo F, Pereira P, et al Soluble selectins, sICAM, sVCAM, and angiogenic proteins in different activity groups of patients with inflammatory bowel disease. Dig Dis Sci,2004,49 (7-8): 1265-1274.
  • 10B. Vainer, H. Nielsen. Changed colonic profile of P-selectin, platelet-endothelial cell adhesion molecule-1 ( PECAM-1 ) ,intercellular adhesion molecule-1 ( ICAM-1 ), ICAM-2, and ICAM-3 in inflammatory bowel disease. Clin Exp Immunol,2000 ,121:242-247.

二级参考文献18

  • 1潘国宗 刘彤华 见:潘国宗 曹世植9. 主编.溃疡性结肠炎[A].见:潘国宗,曹世植9.,主编.现代胃肠病学.第Ⅰ版[C].北京:科学出版社,1994.1246-1247.
  • 2潘国宗 刘彤华.Crohn病[A].见:潘国宗 曹世植 主编.现代胃肠病学[C].北京:科学出版社,1994.1154.
  • 3Ouyang Q,Tandon R,Goh KL,et al.The emergence of inflammatory bowel disease in the Asian Pacific region.Curr Opin Gastroenterol,2005,21 (4):408-413.
  • 4Satsangi J,Silverberg MS,Vermeire S,et al.The Montreal classification of inflammatory bowel disease:controversies,consensus,and implications.Gut,2006,55(6):749-753.
  • 5Kornbluth A,Sachar DB; Practice Parameters Committee of the American College of Gastroenterology.Ulcerative colitis practice guidelines in adults (update):American College of Gastroenterology,Practice Parameters Committee.Am J Gastroenterol,2004,99 (7):1371-1385.
  • 6Hanauer SB,Sandborn W; Practice Parameters Committee of the American College of Gastroenterology.Management of Crohn's disease in adults.Am J Gastroenterol,2001,96 (3):635-643.
  • 7Stange EF,Travis SP,Vermeire S,et al.European Crohn's and Colitis Organisation.European evidence based consensus on the diagnosis and management of Crohn's disease:definitions and diagnosis.Gut,2006,55Suppl 1:i1-i15.
  • 8Carter MJ,Lobo AJ,Travis SP; IBD Section,British Society of Gastroenterology.Guidelines for the management of inflammatory bowel disease in adults.Gut,2004,53 Suppl 5:V1-V16.
  • 9Shivananda S,Hordijk ML,Ten Kate FJ,et al.Differential diagnosis of inflammatory bowel disease.A comparison of various diagnostic classifications.Scand J Gastroenterol,1991,26 (2):167-173.
  • 10樋渡信夫 渡边浩光 前川浩树 等.溃疡性结肠炎的诊断标准与诊断进展[J].炎症性肠疾患胃与肠,1997,32(3):271-278.

共引文献750

同被引文献9

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部